Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Xylem executive Rodney Aulick executes $3.03 million stock sale

Published 07/06/2024, 06:36 am
XYL
-

WASHINGTON, D.C. – Rodney Aulick, the Senior Vice President & President, WSS at Xylem Inc. (NYSE:XYL), a leading water technology company, has recently engaged in significant trading activity involving the company's shares. According to the latest filings, Aulick sold 21,800 shares of Xylem stock at an average price range of $139.00 to $139.07, resulting in a total transaction value of approximately $3.03 million.

The transaction, which took place on June 5, 2024, was part of a series of trades that also included the acquisition of the same number of shares through the exercise of stock options. The options, with a strike price of $49.23 per share, were exercised on the same day as the sale, leading to a calculated total transaction value for the "M" transactions of $1,073,214.

Following the sale, Aulick's direct ownership in the company stands at 76,287 shares of common stock. The recent transactions reflect activity in non-derivative securities and do not involve any derivative positions.

Xylem Inc., headquartered in Washington, D.C., is known for its solutions and technologies focused on addressing water challenges worldwide. The company's shares are publicly traded and closely watched by investors who are interested in the water sector and sustainability-focused companies.

Investors and market watchers pay close attention to insider transactions such as these, as they can provide insights into executives' perspectives on the company's current valuation and future prospects. The details of the trades, including the number of shares sold at each specific price point, are available upon request from the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

The transactions were officially reported on June 6, 2024, following their execution the previous day.

In other recent news, Xylem Inc. has been the subject of several analyst adjustments. TD Cowen has raised its price target on Xylem to $138, maintaining a Buy rating. This revision follows Xylem's Investor Day, which met high expectations and supported consensus estimates of nearly $5.00 per share earnings for the fiscal year 2025. Similarly, Oppenheimer has increased its price target for Xylem to $152, citing the company's strong growth framework and potential for sustained earnings growth. RBC Capital has also maintained an Outperform rating with a $162 price target, emphasizing Xylem's growth strategy and profitability goals.

Argus, on the other hand, raised its price target to $165, praising the company's market outperformance and dividend growth. These analyses come after Xylem's leadership team outlined plans to achieve above-market growth and improve margins through business simplification and integration of the recently acquired Evoqua. The company's long-term financial framework projects annual organic revenue growth of 4% to 6%, with margin expansion expected to accelerate, resulting in mid-teens adjusted earnings per share growth annually. These are the recent developments that have attracted the attention of investors and analysts alike.

InvestingPro Insights

In the context of the recent insider trading activity by Rodney Aulick, Senior Vice President & President, WSS at Xylem Inc. (NYSE:XYL), investors may find value in considering the broader financial performance and market valuation of the company. Xylem, with a market capitalization of $33.18 billion, reflects a significant presence in the water technology sector. The company's shares are trading at a P/E ratio of 48.21, which, when adjusted for the last twelve months as of Q1 2024, stands at 39.04. This indicates a high earnings multiple, suggesting that investors have high expectations for the company's future earnings.

Furthermore, Xylem's revenue growth has been robust, with a 39.51% increase over the last twelve months as of Q1 2024. This growth trajectory is supported by a solid gross profit margin of 36.77% in the same period, indicating the company's ability to maintain profitability amidst its expansion. The dividend yield, as of the latest data, stands at 1.03%, with a notable dividend growth of 9.09% over the last twelve months, showcasing Xylem's commitment to returning value to shareholders.

For those looking to delve deeper into Xylem's financial health and performance, InvestingPro offers additional insights. Notably, the company has raised its dividend for 14 consecutive years and operates with a moderate level of debt, which are positive signals for investors seeking stable, income-generating investments. Moreover, Xylem's liquid assets exceed its short-term obligations, indicating financial resilience. To access more detailed analysis and tips, investors can visit InvestingPro. For a richer experience, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. In total, there are 14 additional InvestingPro Tips available for Xylem, providing investors with a comprehensive understanding of the company's potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.